We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$162B
AUM Growth
+$12.2B
Cap. Flow
+$86.8M
Cap. Flow %
0.05%
Top 10 Hldgs %
24.82%
Holding
2,687
New
205
Increased
908
Reduced
1,482
Closed
45

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.07B
2
NEM icon
Newmont
NEM
+$149M
3
WM icon
Waste Management
WM
+$122M
4
MCD icon
McDonald's
MCD
+$113M
5
LLY icon
Eli Lilly
LLY
+$109M

Sector Composition

Rank Sector Weight
1 Technology 27.15%
2 Healthcare 14.17%
3 Consumer Discretionary 13.27%
4 Communication Services 11.59%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTTB icon
2601
Q32 Bio
QTTB
$459M
$611K ﹤0.01%
4,672
+1,833
+65% +$229K
QTNT
2602
DELISTED
Quotient Limited Ordinary Shares
QTNT
$609K ﹤0.01%
4,180
-435
-9% -$69.6K
VHC icon
2603
VirnetX Holding Corp
VHC
$61.4M
$602K ﹤0.01%
7,050
-255
-3% -$24K
GEF.B icon
2604
Greif Class B
GEF.B
$4.23B
$590K ﹤0.01%
10,000
PUBM icon
2605
PubMatic
PUBM
$804M
$590K ﹤0.01%
+15,100
New +$628K
NKTX icon
2606
Nkarta
NKTX
$167M
$589K ﹤0.01%
18,600
MMX
2607
DELISTED
Maverix Metals Inc. Common Shares
MMX
$589K ﹤0.01%
108,715
-4,300
-4% -$24.6K
PRLD icon
2608
Prelude Therapeutics
PRLD
$424M
$587K ﹤0.01%
+20,500
New +$730K
INBX
2609
DELISTED
Inhibrx, Inc. Common Stock
INBX
$586K ﹤0.01%
21,300
LXRX icon
2610
Lexicon Pharmaceuticals
LXRX
$1.08B
$584K ﹤0.01%
+127,300
New +$613K
MASS icon
2611
908 Devices
MASS
$411M
$581K ﹤0.01%
+15,000
New +$679K
BDTX icon
2612
Black Diamond Therapeutics
BDTX
$120M
$580K ﹤0.01%
47,600
+23,200
+95% +$459K
MTEM
2613
DELISTED
Molecular Templates, Inc.
MTEM
$579K ﹤0.01%
4,933
-180
-4% -$23.6K
AXDX
2614
DELISTED
Accelerate Diagnostics
AXDX
$578K ﹤0.01%
7,170
OTRK
2615
DELISTED
Ontrak
OTRK
$562K ﹤0.01%
192
+15
+8% +$43.3K
EGAN icon
2616
eGain
EGAN
$203M
$561K ﹤0.01%
48,900
KNTE
2617
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$559K ﹤0.01%
+24,000
New +$611K
FF icon
2618
Future Fuel
FF
$279M
$555K ﹤0.01%
57,809
-2,100
-4% -$25.4K
KRRO icon
2619
Korro Bio
KRRO
$196M
$525K ﹤0.01%
1,054
-102
-9% -$49.8K
IHC
2620
DELISTED
Independence Holding Company
IHC
$523K ﹤0.01%
11,300
-600
-5% -$26.6K
BATRA icon
2621
Atlanta Braves Holdings Series A
BATRA
$3.49B
$520K ﹤0.01%
18,422
RUSHB icon
2622
Rush Enterprises Class B
RUSHB
$9.23B
$511K ﹤0.01%
20,100
+900
+5% +$25.8K
FDMT icon
2623
4D Molecular Therapeutics
FDMT
$600M
$496K ﹤0.01%
+20,600
New +$631K
HRTG icon
2624
Heritage Insurance Holdings
HRTG
$957M
$493K ﹤0.01%
57,500
AMAL icon
2625
Amalgamated Financial
AMAL
$1.5B
$481K ﹤0.01%
30,800
-1,800
-6% -$29.1K

Similar funds

Swiss National Bank's Q2 2021 Portfolio in Review

As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
  • Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
  • Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
  • Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
  • Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
  • Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
  • Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.

Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.